Loading...
Lenalidomide Plus Decitabine Treatment in a Myelodysplastic Syndrome Patient With Deletion 5q and Excess Blasts
This is the first case of decitabine plus lenalidomide treatment for a myelodysplastic syndrome (MDS) patient with 5q deletion (del(5q)) and elevated number of blasts. Upon bone marrow aspiration and biopsy with conventional cytogenetical studies she was diagnosed with MDS with del(5q) and refractor...
Na minha lista:
| Udgivet i: | J Hematol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elmer Press
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7188382/ https://ncbi.nlm.nih.gov/pubmed/32362984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jh618 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|